Mission: Cure’s Clinical Trial Archives offer a comprehensive collection of information on pancreatitis research, from past to current clinical trials. Explore opportunities, eligibility details, and insights into advances in treatment and patient care.
In this webinar, Joshua Henderson, Mission: Cure’s Chief Cure Strategy Officer, breaks down the current landscape of pancreatitis research and treatment development, including how many potential treatments Mission: Cure is tracking in its drug development pipeline. He also explores the vital role patients and caregivers play in helping move research forward.
Severely elevated triglycerides often go hand-in-hand with other chronic conditions, including pancreatitis. If you’re managing high triglycerides, you can receive up to $360 in gift cards for joining the meTriG Study. What is the meTriG study? The meTriG Study is app-based and completely remote (no clinic visits required), where you track your everyday health observations.
Chronic abdominal pain is the hallmark symptom of chronic pancreatitis, with many patients seeking medical attention for pain control. While several management options are potentially available to gastroenterologists, outcomes are often disappointing, and opioids remain a mainstay of therapy. This is an NIH-funded phase 1 trial, “Safety, Tolerability and dose-limiting Toxicity of lacosamide in patients
Certain people with chronic pancreatitis are at a high risk of getting pancreatic cancer. In fact, people with pancreatitis and PRSS1 mutations (also known as hereditary pancreatitis) should get screened for pancreatic cancer every year. Unfortunately, for now, there isn’t a test to detect pancreatic cancer early on. To screen for pancreatic cancer, doctors currently
Acute pancreatitis, a life-threatening condition, occurs suddenly and is often idiopathic (meaning, for unknown reasons). Although treatment specific to the disease is lacking, it usually resolves with proper clinical management. Multiple episodes may occur over time, leading to recurrent acute pancreatitis, which can eventually lead to chronic pancreatitis. Chronic pancreatitis is irreversible inflammatory and fibrotic
Mission: Cure has provided initial funding to Johns Hopkins Medicine to launch the new Pancreatitis Pain Research Center. Mission: Cure will work with Johns Hopkins to establish the Pancreatitis Pain Research Program. The goals for the pancreatitis pain program are: To study and treat specific types of pain associated with chronic pancreatitis To create an